Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
Provider: MacroRisk Analytics/EconomicInvestor
Provider: ValuEngine, Inc.
Provider: Sadif Analytics (Premium)

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Akorn Inc receives FTC clearance for Hi-Tech Pharmacal Co Inc acquisition

Monday, 14 Apr 2014 07:00pm EDT 

Akorn Inc:Says that U.S. Federal Trade Commission (FTC) has voted to approve Akorn's acquisition of Hi-Tech Pharmacal Co Inc.Says unanimous vote in support of transactions follows Akorn's agreement to proposed consent order requiring divestiture of certain products as a condition to obtaining FTC approval.Parties have now obtained all regulatory approvals required to consummate the acquisition, and intend to close by end of this week. 

Related Company News

Company Quote

-0.12 -0.32%
19 Aug 2014